Cargando…
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells
Glioblastoma multiforme (GBM) is the most aggressive CNS tumor and is characterized by a very high frequency of clinical relapse after therapy and thus by a dismal prognosis, which strongly compromises patients survival. We have recently identified the small molecule SI113, as a potent and selective...
Autores principales: | Talarico, Cristina, Dattilo, Vincenzo, D'Antona, Lucia, Barone, Agnese, Amodio, Nicola, Belviso, Stefania, Musumeci, Francesca, Abbruzzese, Claudia, Bianco, Cataldo, Trapasso, Francesco, Schenone, Silvia, Alcaro, Stefano, Ortuso, Francesco, Florio, Tullio, Paggi, Marco G., Perrotti, Nicola, Amato, Rosario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941283/ https://www.ncbi.nlm.nih.gov/pubmed/26908461 http://dx.doi.org/10.18632/oncotarget.7520 |
Ejemplares similares
-
Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy
por: Talarico, Cristina, et al.
Publicado: (2015) -
In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug Sensitivity
por: D'Antona, Lucia, et al.
Publicado: (2019) -
The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme
por: Abbruzzese, Claudia, et al.
Publicado: (2017) -
SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation
por: Dattilo, Vincenzo, et al.
Publicado: (2017) -
RANBP1, a member of the nuclear-cytoplasmic trafficking-regulator complex, is the terminal-striking point of the SGK1-dependent Th17(+) pathological differentiation
por: Brescia, Carolina, et al.
Publicado: (2023)